(Reuters) - The company said in a filing with the U.S. Securities and Exchange Commission that it will use the proceeds from the offering for general corporate purposes, including clinical trials, product development, debt repayment, and acquisitions.
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.
Read more at Reuters.com Government Filings News
Under a shelf registration, a company may sell securities in one or more separate offerings with the size, price and terms to be determined at the time of sale.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment